Unknown PHASE3 INTERVENTIONAL 2-arm NCT03970031

A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH

MMONARCh-1: Study of MSDC-0602K, a Modulator of the Mitochondrial Pyruvate Carrier for Outcomes in Patients With Pre Type 2 Diabetes (T2D) or T2D and NAFLD/NASH, Assessed for ImpRoved Glycemic Control and Cardiovascular Outcomes-1

Sponsor: Cirius Therapeutics, Inc.

Conditions NASH - Nonalcoholic Steatohepatitis Non-Alcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis Type2 Diabetes

Interventions MSDC-0602K Placebo

Updated 8 times since 2019 Last updated: Jul 8, 2021 Started: Jun 30, 2022 Primary completion: Sep 30, 2024 Completion: Sep 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03970031, this PHASE3 trial focuses on NASH - Nonalcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease and remains ongoing. Sponsored by Cirius Therapeutics, Inc., it has been updated 8 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Oct 2024 — Present [monthly]

Unknown PHASE3

Status: Not Yet Recruiting → Unknown
Sep 2024 — Oct 2024 [monthly]

Not Yet Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE3
Sep 2021 — Jul 2024 [monthly]

Not Yet Recruiting PHASE3
Feb 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE3

▶ Show 3 earlier versions

Jan 2021 — Feb 2021 [monthly]

Not Yet Recruiting PHASE3
Aug 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3
Jun 2019 — Aug 2020 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cirius Therapeutics, Inc.

Data source: Cirius Therapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.